Drug Trial Radar · NCT03139604
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Last checked: Nov 19, 2026Latest source record: Sep 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
439
Actual
Start
Jul 19, 2017
Primary completion
May 2, 2019
Study completion Jul 13, 2020
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- May 4, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).
Conditions
- Graft-versus-host Disease (GVHD)
Interventions
ItacitinibDrug
Itacitinib at the protocol-defined dose administered orally once daily (QD) plus corticosteroids.
PlaceboDrug
Matching placebo tablets administered orally once daily (QD) plus corticosteroids.
PrednisoneDrug
Oral prednisone may be used to begin standard corticosteroid background treatment at the investigator's discretion, at a dose equivalent to methylprednisolone 2 mg/kg per day.
MethylprednisoloneDrug
Methylprednisolone 2 mg/kg IV daily (or prednisone equivalent) or at a dose appropriate for the severity of disease as background treatment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Response Rate Based on Center for International Blood and Marrow Transplant Research (CIBMTR) Response IndexTime frame: Day 28
Locations
129 sites in 19 countries. Site status is shown where the registry gives one.
University of California, San Diego (UCSD) - Moores Cancer Center
La Jolla, California
University of Southern California
Los Angeles, California
University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, California
Stanford Cancer Center
Stanford, California
University of Colorado - Aurora Cancer Center
Aurora, Colorado
University of Florida (UF) - Division of Hematology & Oncology
Gainesville, Florida
University of Miami - Sylvester Cancer Center
Miami, Florida
Florida Hospital Cancer Institute
Orlando, Florida
University of Illinois at Chicago
Chicago, Illinois
University of Chicago
Chicago, Illinois
Advocate Lutheran General Hospital - Oncology Specialists SC
Park Ridge, Illinois
Indiana University (IU) Melvin and Bren Simon Cancer Center
Indianapolis, Indiana
Indiana Blood and Marrow Transplant
Indianapolis, Indiana
University of Iowa
Iowa City, Iowa
University of Kansas Cancer Center
Westwood, Kansas
Tulane University Medical Center
New Orleans, Louisiana
University of Maryland Medical Center
Baltimore, Maryland
Tufts Medical Center
Boston, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana Farber Cancer Institute
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Henry Ford Hospital
Detroit, Michigan
Spectrum Health
Grand Rapids, Michigan
University of Mississippi Medical Center
Jackson, Mississippi
Washington University School of Medicine
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
John Theurer Cancer Center At Hackensack UMC
Hackensack, New Jersey
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Northwell Health
Lake Success, New York
Columbia University
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Stony Brook University Medical Center
Stony Brook, New York
Levine Cancer Institute
Charlotte, North Carolina
Wake Forest Baptist Medical Center - Wake Forest University School of Medicine
Winston-Salem, North Carolina
Oncology Hematology in Cincinnati
Cincinnati, Ohio
University Hospitals Cleveland Medical Center
Cleveland, Ohio
The Ohio State University (OSU)
Columbus, Ohio
University of Oklahoma - Health Sciences Center
Oklahoma City, Oklahoma
Showing 40 of 129 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.